Multicenter evaluation of the Waveband system for automated sleep assessment in patients with insomnia symptoms
Open Access
- 28 March 2026
- journal article
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 49 (7)
Abstract
Study Objectives: This study (Octave-3) aimed to validate the performance of the Waveband dry-electroencephalography sensor device for automatic sleep staging and sleep parameter estimation as compared to gold-standard in-lab polysomnography (PSG). Methods: Forty-five participants were enrolled, and 38 completed simultaneous PSG and Waveband recordings. PSG data were scored by six human technologists, while Waveband data were scored algorithmically. Agreement between sleep staging results and derived sleep parameters (total sleep time (TST), sleep efficiency (SE), sleep onset latency (SOL), latency to 10 minutes of persistent sleep (LPS), wake after sleep onset (WASO), and time spent in each sleep stage) was measured using the Intraclass Correlation Coefficient (ICC) and overall agreement (OA). Waveband OA was compared to each human rater using the leave-one-out consensus of the remaining five human experts. Results: Average OA between Waveband vs the leave one out consensuses was 87.3+/-5.4 per cent, equivalent to the average OA for individual human experts of 85.9+/-7.6 per cent (p > .1). Waveband and humans had better OA over the second half of the night, but Waveband had superior OA. ICCs for TST, SE, LPS, and WASO exceeded 0.9, indicating excellent agreement between automated Waveband and human PSG scoring. Lower agreement was found for time spent in N1, N3, and Rapid Eye Movement Sleep (REM), with ICCs ranging from 0.65 to 0.73. Conclusions: Waveband provides accurate sleep staging and estimation of TST, SE, SOL, LPS, and WASO, with comparable performance to human expert staging of PSG. Its reduced form-factor and good performance should make it a valuable tool for automated assessment of sleep in patients with disturbed sleep. Clinical Trial Information Trial name: Octave-3. URL: https://www.clinicaltrials.gov/study/NCT05438017 Registration: NCT05438017.Keywords
Funding Information
- Beacon Biosignals
This publication has 34 references indexed in Scilit:
- Day‐to‐day sleep and circadian variability in association with Alzheimer’s Disease biomarkersAlzheimer's & Dementia, 2023
- Objective polysomnography-based sleep features and major depressive disorder subtypes in the general populationPsychiatry Research, 2023
- Polysomnographic predictors of sleep, motor and cognitive dysfunction progression in Parkinson's disease: a longitudinal studySleep Medicine, 2021
- Sleep Disturbance Forecasts β-Amyloid Accumulation across Subsequent YearsCurrent Biology, 2020
- Sleep and EpilepsySleep Medicine Clinics, 2016
- Effect of positive airway pressure therapy on seizure control in patients with epilepsy and obstructive sleep apneaEpilepsy & Behavior, 2014
- REM sleep dysregulation in depression: State of the artSleep Medicine Reviews, 2013
- Movement toward a novel activity monitoring deviceSleep and Breathing, 2011
- Bimodal ultradian seizure periodicity in human mesial temporal lobe epilepsySeizure: European Journal of Epilepsy, 2010
- Slow-wave activity in NREM sleep: sex and age effects in depressed outpatients and healthy controlsPsychiatry Research, 2000